Trial · NCT02952092
Registered outcomes29
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 29
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in the average hemoglobin (Hb) | Baseline and Weeks 18 to 24 | |
| Secondary | Average Hb from Week 18 to Week 24 | Week 18 to 24 | |
| Secondary | Proportion of participants with the target Hb level from Week 18 to Week 24 | Week 18 to 24 | |
| Secondary | Proportion of participants with the target Hb level at each week | Up to Week 24 | |
| Secondary | Change from week 0 in Hb levels to each week | Up to Week 24 | |
| Secondary | Proportion of measurement points with the target Hb level from Week 18 to Week 24 | Week 18 to 24 | |
| Secondary | Rate of rise in Hb levels (g/dL/week) from week 0 to at the earliest date of week 4, time of discontinuation, or time of dose adjustment | Up to Week 4 | |
| Secondary | Average hematocrit level | Up to Week 24 | |
| Secondary | Average reticulocyte level | Up to Week 24 | |
| Secondary | Average iron (Fe) level | Up to Week 24 | |
| Secondary | Average ferritin level | Up to Week 24 | |
| Secondary | Average transferrin level | Up to Week 24 | |
| Secondary | Average total iron binding capacity level | Up to Week 24 | |
| Secondary | Average soluble transferrin receptor level | Up to Week 24 | |
| Secondary | Average transferrin saturation level | Up to Week 24 | |
| Secondary | Average reticulocyte hemoglobin content level | Up to Week 24 | |
| Secondary | Quality of life assessed by SF-36 | Up to Week 24 | SF-36: Medical Outcomes Study 36-Item Short-Form Health Survey |
| Secondary | Quality of life assessed by EQ-5D-5L | Up to Week 24 | EQ-5D-5L: EuroQol 5 Dimension 5-Levels |
| Secondary | Quality of life assessed by FACT-An | Up to Week 24 | FACT-An: Functional Assessment of Cancer Therapy-Anemia |
| Secondary | Number of hospitalizations | Up to Week 24 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02952092/registered